Clinical Trial Update: A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating caspofungin, liposomal amphotericin B, or the combination for invasive fungal infections in patients after hematopoietic stem …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• Caspofungin (caspofungin)
• Liposomal amphotericin B (amphotericin B liposomal)

Snippet

Sponsor: University Hospital Muenster | Conditions: Hematopoietic Stem Cell Transplantation, Fungus Diseases | Phase 2 | Status: COMPLETED